Page last updated: 2024-09-03

sb 200646 and 3,4-dihydroxyphenylacetic acid

sb 200646 has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

Compound Research Comparison

Studies
(sb 200646)
Trials
(sb 200646)
Recent Studies (post-2010)
(sb 200646)
Studies
(3,4-dihydroxyphenylacetic acid)
Trials
(3,4-dihydroxyphenylacetic acid)
Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid)
24055,41038591

Protein Interaction Comparison

ProteinTaxonomysb 200646 (IC50)3,4-dihydroxyphenylacetic acid (IC50)
intestinal alkaline phosphatase precursorMus musculus (house mouse)4.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klodt, PM; Kudrin, VS; Narkevich, VB; Rayevsky, KS1

Other Studies

1 other study(ies) available for sb 200646 and 3,4-dihydroxyphenylacetic acid

ArticleYear
Effect of combined administration of afobazole and 5-HT2b/2c receptor antagonist SB-200646A on neurochemical profile of brain structures in C57Bl/6 and BALB/c mice.
    Bulletin of experimental biology and medicine, 2012, Volume: 153, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Benzimidazoles; Biogenic Monoamines; Brain; Chromatography, High Pressure Liquid; Dopamine; Drug Combinations; Homovanillic Acid; Indoles; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morpholines; Serotonin 5-HT2 Receptor Agonists; Urea

2012